Abstract
Gene therapy is emerging as a potential cure for those battling sickle cell disease, offering optimism for those affected by this debilitating condition. For this promise to be realized, however, significant barriers to access must be mitigated. In this article, we delve into challenges faced by vulnerable populations in accessing cell and gene therapies and explore potential solutions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have